Medicare Enrolled

Dr. Tung-Chin Hsieh, M.D.

Urology Physician · San Diego, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
200 W ARBOR DR # 8220, San Diego, CA 92103
7039154117
In practice since 2008 (17 years)
NPI: 1073758652 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hsieh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hsieh? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hsieh

Dr. Tung-Chin Hsieh is an urology physician in San Diego, CA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Hsieh performed 258,666 Medicare services across 1,067 unique beneficiaries.

Between the years covered by Open Payments, Dr. Hsieh received a total of $253,122 from 27 pharmaceutical and/or device companies across 428 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hsieh is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ Top 0% volume in CA $253,122 industry payments

Medicare Practice Summary

Medicare Utilization ↗
258,666
Medicare services
Top 0% in CA for urology physician
1,067
Unique beneficiaries
$2
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~15,216 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Testosterone undecanoate injection (Aveed)
An injection of testosterone undecanoate, a form of testosterone hormone. This procedure involves administering the medication via injection.
257,250 $1 $7
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
408 $93 $369
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
407 $12 $109
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
113 $114 $559
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
100 $72 $255
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
69 $9 $113
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
55 $201 $769
Ceftriaxone antibiotic injection
This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered.
52 $0 $11
Bladder emptying assessment
A timed evaluation to measure how effectively the bladder empties urine.
49 $11 $184
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
49 $47 $151
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
41 $121 $543
Transrectal ultrasound of the pelvis
An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures.
26 $125 $660
Transurethral prostate removal with electrocautery
This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding.
18 $596 $3,090
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
16 $2 $14
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
13 $185 $848
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$253,122
Total received (2018-2024)
Avg $36,160/year across 7 years
Top 3% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
428
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$181,923 (71.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$63,513 (25.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,687 (3.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$49,648
2023
$46,872
2022
$35,880
2021
$15,194
2020
$27,298
2019
$27,835
2018
$50,396

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$40,302
Endo USA, Inc.
$7,836
Verity Pharmaceuticals Inc.
$1,000
COLOPLAST CORP
$149
Calyxo, Inc.
$136
Antares Pharma, Inc.
$98
Endo Pharmaceuticals Inc.
$85
Laborie Medical Technologies Corp.
$44
Top 3 companies account for 99.0% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$156,041
Endo Pharmaceuticals Inc.
$68,443
Endo USA, Inc.
$7,836
BOSTON SCIENTIFIC CORPORATION
$5,928
Teleflex LLC
$5,230
Coloplast Corp
$5,073
Aytu BioScience, Inc
$2,144
Verity Pharmaceuticals Inc.
$1,000
TerSera Therapeutics LLC
$300
Antares Pharma, Inc.
$263
Medtronic, Inc.
$151
COLOPLAST CORP
$149
Calyxo, Inc.
$136
Olympus America Inc.
$45
Laborie Medical Technologies Corp.
$44
Richard Wolf Medical Instruments Corp.
$40
Supernus Pharmaceuticals, Inc.
$40
Bard Access Systems, Inc.
$37
Metuchen Pharmaceuticals
$35
Sagent Pharmaceuticals, Inc.
$34
UroGen Pharma, Inc.
$33
NxThera, Inc.
$26
NeoTract Inc.
$24
Travere Therapeutics, Inc.
$21
Axonics, Inc.
$19
Ethicon US, LLC
$18
Hollister Incorporated
$14
Top 3 companies account for 91.8% of all-time payments
Associated products mentioned in payments ›
ADVANCE · AMS · AMS 700 · AMS 700 CXR RTE KIT · AMS 700 CXR RTE Kit · AMS 800 Artificial Urinary Sphincter · AMS Ambicor · AVEED · Axonics · CVAC ASPIRATION SYSTEM · EDEX · ENSEAL Product Family · GENERAL ERECTILE DYSFUNCTION · GENERAL BPH · GENERAL ERECTILE DYSFUNCTION · GENERAL THERAPIES · GENERAL - ERECTILE DYSFUNCTION · GENERAL BPH · GENERAL ERECTILE DYSFUNCTION · GENERAL MALE SUI · General - Erectile Dysfunction · General - Therapies · Glydo · INTERSTIM · JELMYTO · NOCDURNA · Natesto · OTREXUP · Optilume BPH Drug Coated Balloon Catheter · Otrexup · PENILE & TESTICULAR RECONSTRUCTN · REZUM · Rezum · Rezum Generator · SOLYX · SPECTRA · Solyx SIS System · Stendra · TACTRA · THERAPIES · TITAN · TLANDO · Thiola · Titan · Tlando · UGN General · UROLIFT · UroLift · UroLift System · VaPro Plus Pocket · XIAFLEX · XYOSTED · iTIND System · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (72%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for urology physician in CA.

Looking for an urology physician in San Diego?
Compare urology physicians in the San Diego area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
131
Per 100K population
4.0
County median income
$102,285
Nearest hospital
UC SAN DIEGO HEALTH HILLCREST - HILLCREST MED CTR
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Hsieh is a mixed practice specialist, with above-average Medicare volume (top 0% in CA), with speaking/promotional industry engagement in the top 3% of CA peers, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Hsieh experienced with testosterone undecanoate injection (aveed)?
Based on Medicare claims data, Dr. Hsieh performed 257,250 testosterone undecanoate injection (aveed) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hsieh receive payments from pharmaceutical companies?
Yes. Dr. Hsieh received a total of $253,122 from 27 companies across 428 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hsieh's costs compare to other urology physicians in San Diego?
Dr. Hsieh's average Medicare payment per service is $2. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hsieh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →